Vassilakopoulou, M. Togun, T. Dafni, U. Cheng, H. Bordeaux, J. Neumeister, V.M. Bobos, M. Pentheroudakis, G. Skarlos, D.V. Pectasides, D. Kotoula, V. Fountzilas, G. Rimm, D.L. Psyrri, A., In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients, PLOS ONE, (9), 2014, Public Library of Science,